Generic Drugs Outlined As ‘Significant Public Health Priority’ For FDA
Generic Cyclosporine Was A Significant Win For FDA Last Year
Executive Summary
The FDA Office of Generic Drugs has published its annual report, highlighting its contributions to the approval of Viatris’ generic cyclosporine rival to Restasis, alongside updates to bioequivalence standards and support for competition.